Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of IFN-alpha-2b Dose Reduction With Dose Optimization

NCT01460875 is registered in ClinicalTrials.gov with William Carson as lead sponsor.

NCT NCT01460875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01460875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of IFN-alpha-2b Dose Reduction With Dose Optimization
Lead sponsor
William Carson
Phase
Not applicable
Overall status
Completed
Start date
April 22, 2008
Completion date
January 5, 2014
Enrollment
34 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage ia skin melanoma, stage ib skin melanoma, stage iia skin melanoma, stage iib skin melanoma, stage iic skin melanoma, stage iiia skin melanoma, stage iiib skin melanoma, stage iiic skin melanoma, stage iv skin melanoma